RACE to Fight NF

#JoinTheRace with NF North Central to stop NF by learning more about the following:

Did You Know?

The number of babies born with NF in the United States Every Day is 4

Highlighted NF-2 Scientific Articles

For the most current research news read The Network Edge which brings you regular updates on thlatest neurofibromatosis (NF) research and clinical advances from recent scientific publications. 

Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation
Phi JH, Kim DG, Chung HT, Lee J, Paek SH, Jung HW

The Neurofibromatosis 2 Protein, Merlin, Regulates Glial Cell Growth in an ErbB2- and Src-Dependent Manner
Houshmandi SS, Emnett RJ, Giovannini M, Gutmann DH

Treatment of progressive neurofibromatosis type 2-related vestibular schwannoma with erlotinib
Plotkin SR, Halpin CF, McKenna MJ, Batchelor TT, Loeffler JS, Barker FG

Merlin Is a Potent Inhibitor of Glioma Growth
Lau YKI, Murray LB, Houshmandi SS, Xu Y, Gutmann DH, Yu Q

CAPE (caffeic acid phenethyl ester)-based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice
Demestre M, Messerli SM, Celli N, ShahhossinimM, Kluwe L, Mautner V, Maruta H

Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates
Mathieu D et al.

Neurofibromatosis Type 2 (NF2): A clinical and molecular view
D. Gareth R. Evans

Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients
Scott R. Plotkin, M.D., Ph.D., Caroline C. O’Donnell, B.A., R.N., William T. Curry Jr., M.D., Catherine M. Bove, M.Ed., A.P.N.G., Mia MacCollin, M.D., and Fabio P. Nunes, M.D.

Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function
Chunzhang Yang, Ashok R. Asthagiri, Rajiv R. Iyer, Jie Lu, David S. Xu, Alexander Ksendzovsky, Roscoe O. Brady, Zhengping Zhuang, and Russell R. Lonser

Following A Path To A Potential Therapy For NF2, A Rare Tumor Disorder
Source: Greg Lester, The Wistar Institute

Psychological distress in people with disfigurement from facial palsy
L. Fu, C. Bundy, and S. A. Sadiq

Hearing Resoration in Neurofibromatosis Type II Patients
Jeon Mi Lee, Jin Woo Chang, Jae Young Choi, Won Seok Chang, and In Seok Moon